NASDAQ$BTTC

Black Titan Corp · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Headline financials

Total Revenue

$121K

Previous: $135K-10.4%
EPS (adj)

-$3.40

Previous: -$5.20+34.6%
Net Income

-$2.57M

No prior period
Operating Income

-$2.61M

No prior period
Gross Profit

$51K

No prior period
Cash & Equivalents

$2.94M

No prior period
Total Assets

$4.06M

No prior period
Stock-Based Comp

-$91K

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$121K

Q4 2022-10.4%vs Q4 2021
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro